Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation.

IF 2.8 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES Supportive Care in Cancer Pub Date : 2025-01-10 DOI:10.1007/s00520-024-09140-8
Matthias Limbach, Rea Kuehl, Maximilian Koeppel, Peter Dreger, Thomas Luft, Martin Bohus, Joachim Wiskemann
{"title":"Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation.","authors":"Matthias Limbach, Rea Kuehl, Maximilian Koeppel, Peter Dreger, Thomas Luft, Martin Bohus, Joachim Wiskemann","doi":"10.1007/s00520-024-09140-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Physical performance is crucial for prognosis after allogeneic hematopoietic stem cell transplantation (allo-HCT). Cardiorespiratory fitness has already been shown to have prognostic value, and there is increasing evidence that muscle strength and associated parameters (e.g., sarcopenia) are also of clinical relevance. Therefore, there is a need for the quantification of muscle strength and defining risk factors for reduced performance values.</p><p><strong>Methods: </strong>Maximal voluntary isokinetic (MVIC) and isometric (MIPT) muscle strength was assessed 2.4 ± 7.1 days prior admission for allo-HCT with a stationary isokinetic testing machine (IsoMed2000). We calculated percentiles for knee extension and hip flexion using healthy reference values. Regression models were used to identify predictors for reduced muscle strength including gender, age, body mass index (BMI), number of previous cardiotoxic therapies, number of previous transplantations, comorbidity index (HCT-CI), hemoglobin level, and physical activity.</p><p><strong>Results: </strong>Data of 212 patients (male n = 143, female n = 69), with a mean age of 54.49 ± 11.4, revealed considerably deviations from healthy reference values. Patients were located in the following percentiles: MVIC<sub>Knee</sub> 37.5 ± 30.3, MVIC<sub>Hip</sub> 39.5 ± 31.3 and MIPT<sub>Knee</sub> 22.9 ± 26.5; MIPT<sub>Hip</sub> 22.6 ± 27.4. Sub-group analyses showed that patients with younger age and male gender possess the highest deviations. Muscle strength values were significantly (p < 0.05) influenced by age, female gender, lower BMI, and higher HCT-CI.</p><p><strong>Conclusion: </strong>Muscle strength is considerably reduced immediately prior to allo-HCT. Identified patient characteristics for reduced muscle strength point to the population that should be primarily targeted with exercise respectively resistance training interventions prior to allo-HCT to contribute to a well prepared transplant candidate.</p><p><strong>Trial registration: </strong>NCT01374399.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 2","pages":"89"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11723852/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supportive Care in Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00520-024-09140-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Physical performance is crucial for prognosis after allogeneic hematopoietic stem cell transplantation (allo-HCT). Cardiorespiratory fitness has already been shown to have prognostic value, and there is increasing evidence that muscle strength and associated parameters (e.g., sarcopenia) are also of clinical relevance. Therefore, there is a need for the quantification of muscle strength and defining risk factors for reduced performance values.

Methods: Maximal voluntary isokinetic (MVIC) and isometric (MIPT) muscle strength was assessed 2.4 ± 7.1 days prior admission for allo-HCT with a stationary isokinetic testing machine (IsoMed2000). We calculated percentiles for knee extension and hip flexion using healthy reference values. Regression models were used to identify predictors for reduced muscle strength including gender, age, body mass index (BMI), number of previous cardiotoxic therapies, number of previous transplantations, comorbidity index (HCT-CI), hemoglobin level, and physical activity.

Results: Data of 212 patients (male n = 143, female n = 69), with a mean age of 54.49 ± 11.4, revealed considerably deviations from healthy reference values. Patients were located in the following percentiles: MVICKnee 37.5 ± 30.3, MVICHip 39.5 ± 31.3 and MIPTKnee 22.9 ± 26.5; MIPTHip 22.6 ± 27.4. Sub-group analyses showed that patients with younger age and male gender possess the highest deviations. Muscle strength values were significantly (p < 0.05) influenced by age, female gender, lower BMI, and higher HCT-CI.

Conclusion: Muscle strength is considerably reduced immediately prior to allo-HCT. Identified patient characteristics for reduced muscle strength point to the population that should be primarily targeted with exercise respectively resistance training interventions prior to allo-HCT to contribute to a well prepared transplant candidate.

Trial registration: NCT01374399.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
影响同种异体干细胞移植候选者移植前肌力的因素。
目的:体能表现对同种异体造血干细胞移植(allogeneic hematopoietic stem cell transplantation, allo-HCT)术后预后至关重要。心肺健康已经被证明具有预后价值,并且越来越多的证据表明肌肉力量和相关参数(如肌肉减少症)也具有临床相关性。因此,有必要对肌肉力量进行量化,并确定降低性能值的危险因素。方法:在入院前2.4±7.1天,使用固定式等速试验机(IsoMed2000)评估最大自主等速(MVIC)和等速(MIPT)肌肉力量。我们使用健康参考值计算膝关节伸展和髋关节屈曲的百分位数。回归模型用于确定肌肉力量减少的预测因素,包括性别、年龄、体重指数(BMI)、既往心脏毒性治疗次数、既往移植次数、合并症指数(HCT-CI)、血红蛋白水平和身体活动。结果:212例患者(男143例,女69例),平均年龄54.49±11.4岁,与健康参考值偏差较大。患者位于以下百分位数:MVICKnee 37.5±30.3,MVICHip 39.5±31.3和MIPTKnee 22.9±26.5;MIPTHip(22.6±27.4)。亚组分析显示,年龄较小的患者和男性患者偏差最大。结论:在进行同种异体hct之前,肌力明显降低。已确定的肌肉力量降低的患者特征表明,在allow - hct之前,应该主要针对运动进行阻力训练干预,以帮助做好充分准备的移植候选人。试验注册:NCT01374399。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Supportive Care in Cancer
Supportive Care in Cancer 医学-康复医学
CiteScore
5.70
自引率
9.70%
发文量
751
审稿时长
3 months
期刊介绍: Supportive Care in Cancer provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and all other interested individuals, groups and institutions with the most recent scientific and social information on all aspects of supportive care in cancer patients. It covers primarily medical, technical and surgical topics concerning supportive therapy and care which may supplement or substitute basic cancer treatment at all stages of the disease. Nursing, rehabilitative, psychosocial and spiritual issues of support are also included.
期刊最新文献
Behind the label: a qualitative study of the self-perceptions of individuals with advanced lung cancer receiving immunotherapy or targeted therapy. Strategies to manage the adverse effects of immunotherapy with dinutuximab beta in neuroblastoma: an Italian experience and literature review. A critical review of randomized controlled trials on topical corticosteroids for the prevention of radiation dermatitis in breast cancer. Care for patients with cancer and substance use disorders: a qualitative study of oncology team experiences. Clinical features, procalcitonin concentration, and bacterial infection in febrile hospitalized cancer patients: a descriptive study and association analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1